Partek Flow Floating License Software Package, renewal year base with 2 options
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has issued a Notice of Intent to award a single-source, firm-fixed-price purchase order to Illumina, Inc. for the renewal of a Partek Flow Floating License Software Package. This software is critical for large-scale statistical analysis and data mining in genomics. The requirement covers a base year with two option years. Responses from interested parties are due by May 26, 2026, at 1:00 PM MST.
Scope of Work
NIAMS requires the renewal of one (1) Floating License for the computational Partek Flow Software Package. This advanced platform supports large-scale genomics data analysis, including bulk RNA-seq, DNA-seq, ChIP-seq/ATAC-seq, microarray, and metagenomics. Essential add-on modules for single-cell and spatial data analysis are needed to support multiple NIAMS Intramural Research Program (IRP) projects, particularly for the Biodata Mining and Discovery Section (BDMS).
Contract & Timeline
- Type: Notice of Intent to Award (Single Source)
- Intended Awardee: Illumina, Inc.
- Duration: Base year (08/10/2026 – 08/09/2027) + two option years (ending 08/09/2029)
- Set-Aside: Not Applicable (Single Source)
- Product Service Code (PSC): 6632 (Analysis Instruments, Medical Laboratory Use)
- NAICS Code: 513210 (Software Publishers)
- Place of Performance: NIH/NIAMS, Bethesda, MD
- Response Due: May 26, 2026, 1:00 PM MST
- Published: May 21, 2026
Justification for Sole Source
The justification for a sole-source award to Illumina, Inc. (formerly Partek Inc.) is based on:
- Proprietary Technology: Partek Inc. is the sole developer and distributor of Partek Flow and its essential add-on tools.
- Continuity of Service and Patient Data: Partek Flow is a core component of BDMS bioinformatics workflows, integrated over the past five years, and crucial for ongoing projects and maintaining analytical capabilities.
- Avoidance of Unacceptable Risk and Cost: Disruption to ongoing projects and research would occur if the license is not renewed, as the platform is widely adopted across NIH institutes.
Submission Instructions
This is a Notice of Intent, not a Request for Quotation (RFQ), and a solicitation will not be issued. However, responsible sources who believe they can meet the requirement may submit a capability statement, proposal, or quotation electronically to the primary point of contact by the response date. The government will determine, at its discretion, whether to compete this action based on responses.
Contact Information
Primary Point of Contact: Dana Monroe, Contract Specialist, dana.monroe@hhs.gov